• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . SARS-CoV-2 vaccines induce a diverse spike-specific CD4+ T cell receptor repertoire in people living with HIV with low CD4 nadirs

tetano

Editor, Senior Moderator
Front Immunol


. 2025 Oct 13:16:1663819.
doi: 10.3389/fimmu.2025.1663819. eCollection 2025. SARS-CoV-2 vaccines induce a diverse spike-specific CD4+ T cell receptor repertoire in people living with HIV with low CD4 nadirs

Alicia Mercado[SUP] #[/SUP][SUP] 1 [/SUP], Joel Sop[SUP] #[/SUP][SUP] 1 [/SUP], Steven Amanat[SUP] #[/SUP][SUP] 2 3 [/SUP], Li Zhang[SUP] 2 3 [/SUP], Natasha M Chida[SUP] 1 [/SUP], Christie R Basseth[SUP] 1 [/SUP], Kelly A Gebo[SUP] 1 [/SUP], Annukka A R Antar[SUP] 1 [/SUP], Kellie N Smith[SUP] 2 3 [/SUP], Zhen Zeng[SUP] #[/SUP][SUP] 2 3 [/SUP], Joel N Blankson[SUP] #[/SUP][SUP] 1 4 [/SUP]



Affiliations
Abstract

People living with HIV with low CD4 T cell nadirs on antiretroviral therapy have suboptimal responses to immunization. We analyzed the SARS-CoV-2 spike-specific CD4+ T cell repertoire in individuals with CD4 nadirs of less than 100 cells/ul who received a primary SARS-CoV-2 mRNA vaccine series as well as the bivalent ancestral/BA.5 spike mRNA vaccine. We tested the hypothesis that antigenic imprinting would result in the preferential expansion of pre-existing cross-reactive T cells that were primed against the 4 common cold coronaviruses. We found that these individuals made robust effector and memory T cell responses to the SARS-CoV-2 spike protein that exceeded the responses to spike proteins from the common cold coronaviruses. Furthermore, in 4 individuals, the number of SARS-CoV-2 specific TCRs far exceeded the number of common cold coronavirus-specific T cell receptors. TCRs that were cross-reactive for common cold coronaviruses and SARS-CoV-2 comprised less than 10% of the total detected SARS-CoV-2 specific T cells. The diversity of the SARS-CoV-2 spike-specific repertoire in 6 study participants was comparable to that of the repertoire in vaccinated HIV healthy donors. Our data suggests people living with HIV with low CD4 nadirs can have significant functional immune reconstitution with little evidence of antigenic imprinting due to pre-existing T cell responses to common cold coronaviruses.

Keywords: CD4 T cell; HIV; SARS-CoV-2; T cell receptor (TCR); common cold coronaviruses.

 
Back
Top Bottom